Table 3.
Unadjusted model |
Adjusting for social demographics |
Adjusting for clinical risks |
Adjusting for social- demographic and clinical risks |
|
---|---|---|---|---|
White | Ref | Ref | Ref | Ref |
Black | 2.53 (1.23–5.20) | 1.47 (0.67–3.25) | 1.90 (0.89–4.06) | 1.33 (0.58–3.05) |
Latino | 4.89 (2.40–9.97) | 3.02 (1.36–6.70) | 3.60 (1.70–7.60) | 2.75 (1.18–6.35) |
Age | 0.97 (0.95–0.99) | 0.97 (0.94–0.99) | ||
Male | Ref | Ref | ||
Female | 1.92 (1.28–2.89) | 1.64 (1.07–2.53) | ||
Income > $15,000/year | Ref | Ref | ||
Low income | 1.26 (0.78–2.01) | 1.14 (0.70–1.86) | ||
Commercial insurance | Ref | Ref | ||
Medicaid | 1.38 (0.72–2.64) | 0.93 (0.47–1.85) | ||
Medicare | 1.34 (0.73–2.47) | 1.02 (0.54–1.95) | ||
Other | 0.81 (0.28–2.38) | 0.86 (0.28–2.62) | ||
No emotional social support | Ref | Ref | ||
Have support | 0.43 (0.23–0.79) | 0.38 (0.20–0.73) | ||
Year since stroke/TIA | 0.99 (0.86–1.13) | 1.00 (0.87–1.15) | ||
Charlson comorbidity < 3 | Ref | Ref | ||
≥ 3 | 1.43 (0.94–2.17) | 1.55 (1.00–2.40) | ||
Functional (mRS 0–2) | Ref | Ref | ||
Disabled (mRS 3–4) | 2.48 (1.67–3.68) | 2.43 (1.59–3.70) | ||
No antidepressant use | Ref | Ref | ||
Used prior to study | 1.85 (1.22–2.81) | 1.85 (1.20–2.85) | ||
Non-smoking | Ref | Ref | ||
Smoking | 1.73 (1.06–2.83) | 1.44 (0.85–2.44) |